Skip to main content

Table 2 Cycle number and reaction rate

From: Adverse infusion reactions to rituximab in systemic lupus erythematosus: a retrospective analysis

RTXa 7 (25%)
RTXb 19 (67.9%)
RTXc 1 (3.6%)
RTXd 1 (3.6%)
  1. NB. 22 patients had 28 reactions
  2. RTXa first infusion of the cycle, RTXb second, RTXc third and RTXd fourth